Schlusskurs
Andere Börsenplätze
|
||
- SEK | - |
2023 | Synokem Pharmaceuticals Limited hat 74% der Anteile an Nitin Lifesciences Limited von Recipharm AB (publ) erworben. | CI |
2023 | Recipharm kündigt Änderungen beim CEO an | CI |
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Grégory Behar
CEO | Chief Executive Officer | 55 | 01.01. |
Director of Finance/CFO | - | 03.04.23 | |
Ulrike Lemke
CTO | Chief Tech/Sci/R&D Officer | - | 01.01.21 |
Luc Burgard
COO | Chief Operating Officer | 43 | - |
Marc Funk
BRD | Director/Board Member | 64 | 01.01.21 |
Human Resources Officer | - | - | |
Kieran Chouhan
PRN | Corporate Officer/Principal | - | 01.02.19 |
Bernard Pluta
PRN | Corporate Officer/Principal | - | 01.10.15 |
Shabbir Mostafa
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | 60 | 01.06.15 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Steven Klosk
BRD | Director/Board Member | 67 | 01.03.21 |
Director/Board Member | 67 | 01.01.21 | |
Richard Ridinger
CHM | Chairman | 66 | 01.03.21 |
Marc Funk
BRD | Director/Board Member | 64 | 01.01.21 |
Director/Board Member | 43 | 01.03.21 | |
Henrik Giver
BRD | Director/Board Member | 35 | 01.01.21 |
Director/Board Member | - | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 370 000 | 0 | 0 | 56,25 % |
Aktie B | 10 | 21 312 000 | 0 | 0 | |
Aktie C | 1 | 79 803 683 | 57 089 305 ( 71,54 %) | 0 |
Unternehmenskontakt
Konzerngesellschaften
Name | Kategorie und Branche |
---|---|
Recipharm Ltd.
Recipharm Ltd. Pharmaceuticals: MajorHealth Technology Recipharm Ltd. manufactures pharmaceutical products. It offers branded and generic products. The company was founded on August 10, 2012 and is headquartered in Ashton-under-Lyne, the United Kingdom. |
Pharmaceuticals: Major
|
Recipharm Venture Fund AB
Recipharm Venture Fund AB Investment ManagersFinance Recipharm Venture Fund AB is a venture capital fund that makes strategic investments in start-ups and biotechnology companies that are seen as important to Recipharm's business. The fund invests in both private and public companies. |
Investment Managers
|
Recipharm Holdings Ltd.
Recipharm Holdings Ltd. MiscellaneousMiscellaneous Recipharm Holdings Ltd. operates from a multipurpose manufacturing facility, The company was founded on August 10, 2012 and is headquartered in Ashton-Under-Lyne, the United Kingdom. |
Miscellaneous
|
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+9,85 % | 72,5 Mrd. | |
+11,69 % | 9,11 Mrd. | |
-12,85 % | 5,07 Mrd. | |
+60,16 % | 5,01 Mrd. | |
+1,60 % | 3,85 Mrd. | |
-19,20 % | 2,46 Mrd. | |
+18,65 % | 2,44 Mrd. | |
+24,62 % | 2,27 Mrd. | |
-27,46 % | 2,26 Mrd. |
- Börse
- Aktien
- A111D5 Aktie
- Aktie
- Unternehmen Recipharm publ AB